Grzegorz Dubin, Professor

Head of the Protein Crystallography Research Group at Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland

Grzegorz Dubin did his PhD at the Jagiellonian University (JU) in Krakow, Poland (under the supervision of Prof. J. Potempa), and at the Max Planck Institute for Biochemistry in Martinsried, Germany (under the guidance of Prof. T. Holak), where he began his work in protein crystallography. Upon returning to Poland, he participated in establishing the Malopolska Centre of Biotechnology at JU, where he founded an independent crystallography research group, which he has led since 2012, currently as a full professor. In 2024, he was a visiting professor at Harvard Medical School in the laboratory of Prof. T. Rapoport. Dubin’s early research focused on the characterization of virulence factors of the dangerous human pathogen Staphylococcus aureus. Currently, his laboratory is dedicated to the structural and functional characterization of promising therapeutic targets in cancer and neglected tropical diseases. He has co-authored more than 120 scientific articles.

In addition to his basic research, G. Dubin has been involved in R&D and translational activities, contributing to the growth of the biotechnology company BioCentrum Ltd. Later, he organized Preparatis Ltd., where he served as CEO from 2014 to 2018.